Trial intelligence / Profile preview

Bioequivalence of Estradiol Vaginal Inserts vs Vagifem in VVA

NCT01779947Phase 3Completed

Sponsor
Amneal Pharmaceuticals, Inc.
Start
Mar 2012
Primary completion
Sep 2012
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 3 trial of estradiol in atrophic vaginitis, sponsored by Amneal Pharmaceuticals, Inc.. Started Mar 2012; status: completed.

02

Drugs

estradiol
03

Conditions

atrophic vaginitis

Beyond the preview

Go deeper on NCT01779947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01779947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call